Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Margaret E. Haerr
Introduction
Margaret E. Haerr is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions. Her work focuses on innovative solutions for treating diseases, including cancer.
Latest Patents
Margaret E. Haerr holds a patent for "DLL3 single domain antibodies and therapeutic compositions thereof." This patent includes binding polypeptides that specifically target DLL3. The invention encompasses fusion proteins, including multivalent and/or multispecific constructs and chimeric antigen receptors that bind DLL3. Additionally, the patent covers pharmaceutical compositions containing these polypeptides, nucleic acid molecules encoding them, and methods for their use in treating various diseases and conditions.
Career Highlights
Haerr is currently associated with Inhibrx Biosciences, Inc., where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in the biotechnology sector, contributing to the advancement of therapeutic options for patients.
Collaborations
Some of her notable coworkers include Brendan P. Eckelman and Michael D. Kaplan, who collaborate with her on various projects within the company.
Conclusion
Margaret E. Haerr's contributions to biotechnology and her innovative patent for DLL3 binding polypeptides highlight her role as a leading inventor in the field. Her work continues to pave the way for new therapeutic approaches to combat serious diseases.